2014
Fleming ST, Hamilton AS, Sabatino SA, Kimmick GG, Wu XC, Owen JB, Huang B, Hwang W. Treatment patterns for prostate cancer: comparison of medicare claims data to medical record review. Med Care. 2014 Sep; 52(9):e58-64.
Goldenberg D, Mackley H, Koch W, Bann DV, Schaefer EW, Hollenbeak CS. Age and stage as determinants of treatment for oral cavity and oropharyngeal cancers in the elderly. Oral Oncol. 2014 Oct; 50(10):976-82.
2013
Boltz MM, Hollenbeak CS, Schaefer E, Goldenberg D, Saunders BD. Attributable costs of differentiated thyroid cancer in the elderly Medicare population. Surgery. 2013 Dec; 154(6):1363-9.
Boltz MM, Enomoto LM, Ornstein RM, Saunders BD, Hollenbeak CS. Incidence and survival differences of differentiated thyroid cancer among younger women. Clinical Oncology in Adolescents and Young Adults. 2013; 3: 79-88.
Hollenbeak CS, Boltz MM, Schaefer EW, Saunders BD, Goldenberg D. Recurrence of differentiated thyroid cancer in the elderly. Eur J Endocrinol. 2013 Mar 15; 168(4):549-56.
Stewart DB, Hollenbeak CS, Desharnais S, Camacho F, Gladowski P, Goff VL, Wang L. Rectal cancer and teaching hospitals: hospital teaching status affects use of neoadjuvant radiation and survival for rectal cancer patients. Ann Surg Oncol. 2013 Apr; 20(4):1156-63.
Wilson MS, Deeter D, Rafferty C, Comito MM, Hollenbeak CS. Reduction of Central Line Associated Bloodstream Infection in a Pediatric Hematology/Oncology Population. Am J Med Qual. 2013 Nov 13. [Epub ahead of print].
2011
Hollenbeak CS, Farley Short P, Moran J. The implications of cancer survivorship for spousal employment. J Cancer Surviv. 2011 Sep; 5(3):226-34.
Hollenbeak CS, Wang L, Schneider P, Goldenberg D. Outcomes of thyroid cancer in African Americans. Ethn Dis. 2011 Spring; 21(2):210-5.
Hollenbeak CS, Nikkel LE, Schaefer EW, Alemao E, Ghahramani N, Raman JD. Determinants of Medicare all-cause costs among elderly patients with renal cell carcinoma. J Manag Care Pharm. 2011 Oct; 17(8):610-20.
Moran JR, Short PF, Hollenbeak CS. Long-term employment effects of surviving cancer. J Health Econ. 2011 May; 30(3):505-14.
Raman JD, Messer J, Sielatycki JA, Hollenbeak CS. Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973-2005. BJU Int. Apr 2011; 107(7):1059-1064.
Stewart DB, Hollenbeak CS, Boltz M. Laparoscopic and open abdominoperineal resection for cancer: how patient selection and complications differ by approach. J Gastrointest Surg. 2011 Nov; 15(11):1928-38.
Uemura T, Riley TR, Khan A, Hollenbeak CS, Schreibman I, Ghahramani N, Reeves B, Domen RE, Zander DS, Kadry Z. Immune functional assay for immunosuppressive management in post-transplant malignancy. Clin Transplant. 2011 Jan-Feb; 25(1):E32-7.
Wang L, Wilson SE, Stewart DB, Hollenbeak CS. Marital status and colon cancer outcomes in US surveillance, epidemiology and end results registries: does marriage affect cancer survival by gender and stage? Cancer Epidemiol. 2011; 35(5):417-422.
2010
Wang L, Hollenbeak CS, Stewart DB. Node yield and node involvement in young colon cancer patients: is there a difference in cancer survival based on age? J Gastrointest Surg. 2010 Sep; 14(9):1355-61.
2009
Goldenberg D, Brooksby C, Hollenbeak CS. Age as a determinant of outcomes for patients with oral cancer. Oral Oncol. 2009; 45(8):e57-e61.